THE global market for gluten-free
products is set to grow by $1.2
billion over the next five years,
according to market analyst
Datamonitor, with predictions that
the GF market in Australia will be
worth US$98.6 million - growing at
one of the highest rates in the Asia-
Pacific region.The above article was sent to subscribers in Pharmacy Daily's issue from 13 Jul 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Jul 10
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.